← FDA Drug Approvals (Drugs@FDA)

DOCETAXEL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INGENUS PHARMS LLC · Approved 2017-08-31

Drug application

FDA Application #

ANDA207563

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOCETAXEL

Generic name

Docetaxel

Active ingredients

DOCETAXEL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

INGENUS PHARMS LLC

First approval

2017-08-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown